BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin A, Zhang J, Luo P. Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer. Front Immunol 2020;11:2039. [PMID: 32903444 DOI: 10.3389/fimmu.2020.02039] [Cited by in Crossref: 83] [Cited by in F6Publishing: 91] [Article Influence: 27.7] [Reference Citation Analysis]
Number Citing Articles
1 Liang L, Liu L, Mai S, Chen Y. A novel machine learning model based on ubiquitin-related gene pairs and clinical features to predict prognosis and treatment effect in colon adenocarcinoma. Eur J Med Res 2023;28:41. [PMID: 36681855 DOI: 10.1186/s40001-023-00993-z] [Reference Citation Analysis]
2 Mirza S, Bhadresha K, Mughal MJ, McCabe M, Shahbazi R, Ruff P, Penny C. Liquid biopsy approaches and immunotherapy in colorectal cancer for precision medicine: Are we there yet? Front Oncol 2022;12:1023565. [PMID: 36686736 DOI: 10.3389/fonc.2022.1023565] [Reference Citation Analysis]
3 Zhang M, Cao C, Li X, Gu Q, Xu Y, Zhu Z, Xu D, Wei S, Chen H, Yang Y, Gao H, Yu L, Li J. Five EMT-related genes signature predicts overall survival and immune environment in microsatellite instability-high gastric cancer. Cancer Med 2023;12:2075-88. [PMID: 35789544 DOI: 10.1002/cam4.4975] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Erwin GS, Gürsoy G, Al-Abri R, Suriyaprakash A, Dolzhenko E, Zhu K, Hoerner CR, White SM, Ramirez L, Vadlakonda A, Vadlakonda A, von Kraut K, Park J, Brannon CM, Sumano DA, Kirtikar RA, Erwin AA, Metzner TJ, Yuen RKC, Fan AC, Leppert JT, Eberle MA, Gerstein M, Snyder MP. Recurrent repeat expansions in human cancer genomes. Nature 2023;613:96-102. [PMID: 36517591 DOI: 10.1038/s41586-022-05515-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhang Y, Li L, Chu F, Zhang L, Zhang L, Wu H, Li K. The tumor microenvironment in gastrointestinal adenocarcinomas revealed a prognostic and immunotherapeutic biomarker. Aging (Albany NY) 2022;14:10171-216. [PMID: 36585927 DOI: 10.18632/aging.204463] [Reference Citation Analysis]
6 Lan H, Yuan J, Zhang R, Jiang B, Li Q, Huang Z, Chen P, Xiang H, Zeng X, Xiao S. Pancancer analysis of SKA1 mutation and its association with the diagnosis and prognosis of human cancers. Genomics 2022;115:110554. [PMID: 36587749 DOI: 10.1016/j.ygeno.2022.110554] [Reference Citation Analysis]
7 Zhou Z, Wu J, Ma W, Dong F, Wang J. Pan-Cancer analyses of Necroptosis-Related genes as a potential target to predict immunotherapeutic outcome. J Cell Mol Med 2023;27:204-21. [PMID: 36583248 DOI: 10.1111/jcmm.17634] [Reference Citation Analysis]
8 Chen X, Feng L, Huang Y, Wu Y, Xie N. Mechanisms and Strategies to Overcome PD-1/PD-L1 Blockade Resistance in Triple-Negative Breast Cancer. Cancers (Basel) 2022;15. [PMID: 36612100 DOI: 10.3390/cancers15010104] [Reference Citation Analysis]
9 Wang X, Huang Z, Li L, Yang Y, Zhang J, Wang L, Yuan J, Li Y. The Role of Alternative Splicing Factors, DDB2-Related Ageing and DNA Damage Repair in the Progression and Prognosis of Stomach Adenocarcinoma Patients. Genes (Basel) 2022;14. [PMID: 36672781 DOI: 10.3390/genes14010039] [Reference Citation Analysis]
10 Gazzillo A, Polidoro MA, Soldani C, Franceschini B, Lleo A, Donadon M. Relationship between Epithelial-to-Mesenchymal Transition and Tumor-Associated Macrophages in Colorectal Liver Metastases. Int J Mol Sci 2022;23. [PMID: 36555840 DOI: 10.3390/ijms232416197] [Reference Citation Analysis]
11 Liang Z, Sun R, Tu P, Liang Y, Liang L, Liu F, Bian Y, Yin G, Zhao F, Jiang M, Gu J, Tang D. Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma. Front Immunol 2022;13:944286. [PMID: 36591255 DOI: 10.3389/fimmu.2022.944286] [Reference Citation Analysis]
12 Huang X, Zhu B, Qian C, Feng Y. The prognostic index of m(7)G-related genes in CRC correlates with immune infiltration. Sci Rep 2022;12:21282. [PMID: 36482181 DOI: 10.1038/s41598-022-25823-w] [Reference Citation Analysis]
13 Kwart D, He J, Srivatsan S, Lett C, Golubov J, Oswald EM, Poon P, Ye X, Waite J, Zaretsky AG, Haxhinasto S, Au-Yeung E, Gupta NT, Chiu J, Adler C, Cherravuru S, Malahias E, Negron N, Lanza K, Coppola A, Ni M, Song H, Wei Y, Atwal GS, Macdonald L, Oristian NS, Poueymirou W, Jankovic V, Fury M, Lowy I, Murphy AJ, Sleeman MA, Wang B, Skokos D. Cancer cell-derived type I interferons instruct tumor monocyte polarization. Cell Rep 2022;41:111769. [PMID: 36476866 DOI: 10.1016/j.celrep.2022.111769] [Reference Citation Analysis]
14 Akter R, Kim K, Kwon HY, Kim Y, Eom YW, Cho HM, Cho MY. EMR1/ADGRE1 Expression in Cancer Cells Upregulated by Tumor-Associated Macrophages Is Related to Poor Prognosis in Colorectal Cancer. Biomedicines 2022;10. [PMID: 36551877 DOI: 10.3390/biomedicines10123121] [Reference Citation Analysis]
15 Han S, Chok AY, Peh DYY, Ho JZ, Tan EKW, Koo S, Tan IB, Ong JC. The distinct clinical trajectory, metastatic sites, and immunobiology of microsatellite-instability-high cancers. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.933475] [Reference Citation Analysis]
16 Al-mterin MA, Murshed K, Elkord E. PD-1 expression, among other immune checkpoints, on tumor-infiltrating NK and NKT cells is associated with longer disease-free survival in treatment-naïve CRC patients. Cancer Immunol Immunother 2022. [DOI: 10.1007/s00262-022-03337-8] [Reference Citation Analysis]
17 Hou W, Yi C, Zhu H. Predictive biomarkers of colon cancer immunotherapy: Present and future. Front Immunol 2022;13:1032314. [PMID: 36483562 DOI: 10.3389/fimmu.2022.1032314] [Reference Citation Analysis]
18 Huang X, Chen Z, Xiang X, Liu Y, Long X, Li K, Qin M, Long C, Mo X, Tang W, Liu J. Comprehensive multi-omics analysis of the m7G in pan-cancer from the perspective of predictive, preventive, and personalized medicine. EPMA J 2022;13:671-97. [PMID: 36505892 DOI: 10.1007/s13167-022-00305-1] [Reference Citation Analysis]
19 Li F, Niu Y, Zhao W, Yan C, Qi Y. Construction and validation of a prognostic model for lung adenocarcinoma based on endoplasmic reticulum stress-related genes. Sci Rep 2022;12:19857. [PMID: 36400857 DOI: 10.1038/s41598-022-23852-z] [Reference Citation Analysis]
20 Zhang Y, Zhang Q, Han X, Han L, Wang T, Hu J, Li L, Ding Z, Shi X, Qian X. SLAMF8, a potential novel immune checkpoint molecule, is associated with the prognosis of colorectal cancer.. [DOI: 10.21203/rs.3.rs-2239673/v1] [Reference Citation Analysis]
21 Chen M, Wang Z, Liu Z, Liu N, Fang W, Zhang H, Jin X, Li J, Zhao W, Qu H, Song F, Chang Z, Li Y, Tang Y, Xu C, Zhang X, Wang X, Peng Z, Cai J, Li J, Shen L. The Optimal Therapy after Progression on Immune Checkpoint Inhibitors in MSI Metastatic Gastrointestinal Cancer Patients: A Multicenter Retrospective Cohort Study. Cancers (Basel) 2022;14:5158. [PMID: 36291942 DOI: 10.3390/cancers14205158] [Reference Citation Analysis]
22 Niu Y, Tang S. Circadian clock-mediated nuclear receptors in cancer. J Cell Physiol 2022. [PMID: 36250982 DOI: 10.1002/jcp.30905] [Reference Citation Analysis]
23 Yu H, Liu S, Wu Z, Gao F, Ali Sheikh MS. GNAI2 Is a Risk Factor for Gastric Cancer: Study of Tumor Microenvironment (TME) and Establishment of Immune Risk Score (IRS). Oxidative Medicine and Cellular Longevity 2022;2022:1-35. [DOI: 10.1155/2022/1254367] [Reference Citation Analysis]
24 Sun Z, Li G, Shang D, Zhang J, Ai L, Liu M. Identification of microsatellite instability and immune-related prognostic biomarkers in colon adenocarcinoma. Front Immunol 2022;13:988303. [DOI: 10.3389/fimmu.2022.988303] [Reference Citation Analysis]
25 Walker P. Liquid Biopsy and the Translational Bridge from the TIME to the Clinic. Cells 2022;11:3114. [DOI: 10.3390/cells11193114] [Reference Citation Analysis]
26 Zhang W, Shi Y, Niu S, Li L, Lin L, Gao X, Cai W, Chen Y, Zhong Y, Tang D, Tang M, Dai Y. Integrated computer analysis and a self-built Chinese cohort study identified GSTM2 as one survival-relevant gene in human colon cancer potentially regulating immune microenvironment. Front Oncol 2022;12:881906. [DOI: 10.3389/fonc.2022.881906] [Reference Citation Analysis]
27 Ding Y, Wang Z, Zhou F, Chen C, Qin Y. Associating resistance to immune checkpoint inhibitors with immunological escape in colorectal cancer. Front Oncol 2022;12:987302. [DOI: 10.3389/fonc.2022.987302] [Reference Citation Analysis]
28 Chen S, Zhang S, Chen S, Ma F. The Prognostic Value and Immunological Role of CD44 in Pan-Cancer Study.. [DOI: 10.21203/rs.3.rs-2109334/v1] [Reference Citation Analysis]
29 Anwer ST, Mobashir M, Fantoukh OI, Khan B, Imtiyaz K, Naqvi IH, Rizvi MMA. Synthesis of Silver Nano Particles Using Myricetin and the In-Vitro Assessment of Anti-Colorectal Cancer Activity: In-Silico Integration. IJMS 2022;23:11024. [DOI: 10.3390/ijms231911024] [Reference Citation Analysis]
30 Fang ZX, Li CL, Chen WJ, Wu HT, Liu J. Potential of six-transmembrane epithelial antigen of the prostate 4 as a prognostic marker for colorectal cancer. World J Gastrointest Oncol 2022; 14(9): 1675-1688 [DOI: 10.4251/wjgo.v14.i9.1675] [Reference Citation Analysis]
31 Pan R, Pan F, Zeng Z, Lei S, Yang Y, Yang Y, Hu C, Chen H, Tian X. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy. Front Immunol 2022;13:1017120. [DOI: 10.3389/fimmu.2022.1017120] [Reference Citation Analysis]
32 Yuan M, Jia Y, Xing Y, Wang Y, Liu Y, Liu X, Liu D. Screening and validation of platelet activation-related lncRNAs as potential biomarkers for prognosis and immunotherapy in gastric cancer patients. Front Genet 2022;13:965033. [DOI: 10.3389/fgene.2022.965033] [Reference Citation Analysis]
33 Du X, Xia W, Fan W, Shen X, Wu H, Zhang H, Gundamaraju R. Integrated Analysis of C16orf54 as a Potential Prognostic, Diagnostic, and Immune Marker across Pan-Cancer. Disease Markers 2022;2022:1-25. [DOI: 10.1155/2022/9365046] [Reference Citation Analysis]
34 Shi C, Qin K, Lin A, Jiang A, Cheng Q, Liu Z, Zhang J, Luo P. The role of DNA damage repair (DDR) system in response to immune checkpoint inhibitor (ICI) therapy. J Exp Clin Cancer Res 2022;41:268. [DOI: 10.1186/s13046-022-02469-0] [Reference Citation Analysis]
35 El-Hajjar M, Gerhardt L, Hong MMY, Krishnamoorthy M, Figueredo R, Zheng X, Koropatnick J, Maleki Vareki S. Inducing mismatch repair deficiency sensitizes immune-cold neuroblastoma to anti-CTLA4 and generates broad anti-tumor immune memory. Mol Ther 2022:S1525-0016(22)00554-8. [PMID: 36068918 DOI: 10.1016/j.ymthe.2022.08.025] [Reference Citation Analysis]
36 Lu J, Tan J, Yu X. A Prognostic Ferroptosis-Related lncRNA Model Associated With Immune Infiltration in Colon Cancer. Front Genet 2022;13:934196. [DOI: 10.3389/fgene.2022.934196] [Reference Citation Analysis]
37 Gao Z, Chen J, Zhou Y, Deng P, Sun L, Qi J, Zhang P, Zheng M. A Novel Metabolism-Related Gene Signature for Predicting the Prognosis of HBV-Infected Hepatocellular Carcinoma. Journal of Oncology 2022;2022:1-17. [DOI: 10.1155/2022/2391265] [Reference Citation Analysis]
38 Erwin GS, Gürsoy G, Al-abri R, Suriyaprakash A, Dolzhenko E, Zhu K, Hoerner CR, White SM, Ramirez L, Vadlakonda A, Vadlakonda A, von Kraut K, Park J, Brannon CM, Sumano DA, Kirtikar RA, Erwin AA, Metzner TJ, Yuen RKC, Fan AC, Leppert JT, Eberle MA, Gerstein M, Snyder MP. A genome-wide atlas of recurrent repeat expansions in human cancer.. [DOI: 10.1101/2022.08.24.505159] [Reference Citation Analysis]
39 Ding K, He Y, Wei J, Fu S, Wang J, Chen Z, Zhang H, Qu Y, Liang K, Gong X, Qiu L, Chen D, Xiao B, Du H. A score of DNA damage repair pathway with the predictive ability for chemotherapy and immunotherapy is strongly associated with immune signaling pathway in pan-cancer. Front Immunol 2022;13:943090. [DOI: 10.3389/fimmu.2022.943090] [Reference Citation Analysis]
40 Zhao Z, Liu H, Fang D, Zhou X, Zhao S, Zhang C, Ye J, Xu J. Patient stratification based on urea cycle metabolism for exploration of combination immunotherapy in colon cancer. BMC Cancer 2022;22:883. [PMID: 35962309 DOI: 10.1186/s12885-022-09958-7] [Reference Citation Analysis]
41 Zhou X, Sun Q, Xu C, Zhou Z, Chen X, Zhu X, Huang Z, Wang W, Shi Y. A systematic pan-cancer analysis of PXDN as a potential target for clinical diagnosis and treatment. Front Oncol 2022;12:952849. [DOI: 10.3389/fonc.2022.952849] [Reference Citation Analysis]
42 Hou D, Ling P, Zhu Y, Ouyang Y, Karmakar B. White tea extract modified green synthesis of magnetite supported Ag nanoparticles: evaluation of its catalytic activity, antioxidant and anti-colon cancer effects. Arabian Journal of Chemistry 2022. [DOI: 10.1016/j.arabjc.2022.104219] [Reference Citation Analysis]
43 Liu J, Geng R, Zhong Z, Zhang Y, Ni S, Liu W, Du M, Bai J, Roy S. N1-Methyladenosine-Related lncRNAs Are Potential Biomarkers for Predicting Prognosis and Immune Response in Uterine Corpus Endometrial Carcinoma. Oxidative Medicine and Cellular Longevity 2022;2022:1-32. [DOI: 10.1155/2022/2754836] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Mou W, Zhu L, Yang T, Lin A, Lyu Q, Guo L, Liu Z, Cheng Q, Zhang J, Luo P. Relationship between ATOH1 and tumor microenvironment in colon adenocarcinoma patients with different microsatellite instability status. Cancer Cell Int 2022;22:229. [PMID: 35836254 DOI: 10.1186/s12935-022-02651-6] [Reference Citation Analysis]
45 Li D, Jiang S, Zhou X, Si C, Shao P, Jiang Q, Zhu L, Shen L, Meng Q, Yin JC, Shao Y, Sun Y, Yang L. FBXW7 and Its Downstream NOTCH Pathway Could be Potential Indicators of Organ-Free Metastasis in Colorectal Cancer. Front Oncol 2021;11:783564. [PMID: 35712679 DOI: 10.3389/fonc.2021.783564] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Almasabi S, Boyd R, Ahmed AU, Williams BRG. Integrin-Linked Kinase Expression Characterizes the Immunosuppressive Tumor Microenvironment in Colorectal Cancer and Regulates PD-L1 Expression and Immune Cell Cytotoxicity. Front Oncol 2022;12:836005. [PMID: 35692780 DOI: 10.3389/fonc.2022.836005] [Reference Citation Analysis]
47 Lin A, Gu T, Hu X, Zhang J, Luo P, Tang B. Comprehensive Analysis Identifies PI3K/Akt Pathway Alternations as an Immune-Related Prognostic Biomarker in Colon Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitor Treatment. Journal of Immunology Research 2022;2022:1-14. [DOI: 10.1155/2022/8179799] [Reference Citation Analysis]
48 Wang C, Karmakar B, Awwad NS, Ibrahium HA, El-kott AF, Abdel-daim MM, Oyouni AAA, Al-amer O, El-saber Batiha G. Bio-supported of Cu nanoparticles on the surface of Fe3O4 magnetic nanoparticles mediated by Hibiscus sabdariffa extract: Evaluation of its catalytic activity for synthesis of pyrano[3,2-c]chromenes and study of its anti-colon cancer properties. Arabian Journal of Chemistry 2022;15:103809. [DOI: 10.1016/j.arabjc.2022.103809] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
49 Huang X, Cao Y, Bao P, Zhu B, Cheng Z. High expression of PI4K2A predicted poor prognosis of colon adenocarcinoma (COAD) and correlated with immunity. Cancer Med 2023;12:837-51. [PMID: 35634680 DOI: 10.1002/cam4.4895] [Reference Citation Analysis]
50 Lu L, Zhao Q, Wang Z, Ju F. Oak gum mediated sustainable synthesis of gold nanoparticles (Au NPs): evaluation of its antioxidant and anti-colon cancer effects. Journal of Experimental Nanoscience 2022;17:377-88. [DOI: 10.1080/17458080.2022.2050905] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Dong J, Qian Y, Zhang G, Lu L, Zhang S, Ji G, Zhao A, Xu H. Can Natural Products be Used to Overcome the Limitations of Colorectal Cancer Immunotherapy? Front Oncol 2022;12:884423. [PMID: 35600371 DOI: 10.3389/fonc.2022.884423] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Lin A, Qi C, Li M, Guan R, Imyanitov EN, Mitiushkina NV, Cheng Q, Liu Z, Wang X, Lyu Q, Zhang J, Luo P. Deep Learning Analysis of the Adipose Tissue and the Prediction of Prognosis in Colorectal Cancer. Front Nutr 2022;9:869263. [DOI: 10.3389/fnut.2022.869263] [Reference Citation Analysis]
53 Wang L, Zhou S, Zhou Y, Lu J, Wang F. A Two-eRNA-Based Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma. Journal of Immunology Research 2022;2022:1-18. [DOI: 10.1155/2022/8069858] [Reference Citation Analysis]
54 Zhen Z, Shen Z, Sun P. Dissecting the Role of Immune Checkpoint Regulation Patterns in Tumor Microenvironment and Prognosis of Gastric Cancer. Front Genet 2022;13:853648. [PMID: 35518357 DOI: 10.3389/fgene.2022.853648] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Hu X, Zhu H, Chen B, He X, Shen Y, Zhang X, Xu Y, Xu X. The oncogenic role of tubulin alpha-1c chain in human tumours. BMC Cancer 2022;22:498. [PMID: 35513790 DOI: 10.1186/s12885-022-09595-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
56 Qi W, Zhang Q. Identification and Validation of Immune Molecular Subtypes and Immune Landscape Based on Colon Cancer Cohort. Front Med 2022;9:827695. [DOI: 10.3389/fmed.2022.827695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Duan L, Wang J, Zhang D, Yuan Y, Tang L, Zhou Y, Jiang X. Immune-Related miRNA-195-5p Inhibits the Progression of Lung Adenocarcinoma by Targeting Polypyrimidine Tract-Binding Protein 1. Front Oncol 2022;12:862564. [DOI: 10.3389/fonc.2022.862564] [Reference Citation Analysis]
58 Cleyle J, Hardy MP, Minati R, Courcelles M, Durette C, Lanoix J, Laverdure JP, Vincent K, Perreault C, Thibault P. Immunopeptidomic analyses of colorectal cancers with and without microsatellite instability. Mol Cell Proteomics 2022;21:100228. [PMID: 35367648 DOI: 10.1016/j.mcpro.2022.100228] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
59 Zhou Z, Xu S, Jiang L, Tan Z, Wang J. A Systematic Pan-Cancer Analysis of CASP3 as a Potential Target for Immunotherapy. Front Mol Biosci 2022;9:776808. [DOI: 10.3389/fmolb.2022.776808] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
60 Seo MK, Kang H, Kim S. Tumor microenvironment-aware, single-transcriptome prediction of microsatellite instability in colorectal cancer using meta-analysis. Sci Rep 2022;12:6283. [PMID: 35428835 DOI: 10.1038/s41598-022-10182-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Lin A, Qi C, Wei T, Li M, Cheng Q, Liu Z, Luo P, Zhang J. CAMOIP: a web server for comprehensive analysis on multi-omics of immunotherapy in pan-cancer. Brief Bioinform 2022:bbac129. [PMID: 35395670 DOI: 10.1093/bib/bbac129] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
62 Qiu T, Wang X, Du F, Hu X, Sun F, Song C, Zhao J. TET1 mutations as a predictive biomarker for immune checkpoint inhibitors in colon adenocarcinoma. World J Surg Oncol 2022;20:115. [PMID: 35395805 DOI: 10.1186/s12957-022-02581-7] [Reference Citation Analysis]
63 Xia T, Guo J, Zhang B, Xue W, Deng S, Liu Y, Cui B. A Novel Quantification System Combining iTRAQ Technology and Multi-Omics Assessment to Predict Prognosis and Immunotherapy Efficacy in Colon Cancer. Front Bioeng Biotechnol 2022;10:862619. [DOI: 10.3389/fbioe.2022.862619] [Reference Citation Analysis]
64 Wu L, Wang X, He X, Li Q, Hua Q, Liu R, Qiu Z. MMP9 Expression Correlates With Cisplatin Resistance in Small Cell Lung Cancer Patients. Front Pharmacol 2022;13:868203. [DOI: 10.3389/fphar.2022.868203] [Reference Citation Analysis]
65 Yang G, Tanaka T, Kinugasa H, Kanzaki H, Chen MX, Ichimura K, Nakagawa M, Jin ZS, Zheng RY, Yoshino T. Microsatellite Instability Analysis and Its Prognostic Value in Invasive Nonampullary Duodenal Adenocarcinoma. Oncology 2022;:1-12. [PMID: 35350032 DOI: 10.1159/000519805] [Reference Citation Analysis]
66 Boukouris AE, Theochari M, Stefanou D, Papalambros A, Felekouras E, Gogas H, Ziogas DC. Latest evidence on immune checkpoint inhibitors in metastatic colorectal cancer: A 2022 update. Crit Rev Oncol Hematol 2022;:103663. [PMID: 35351582 DOI: 10.1016/j.critrevonc.2022.103663] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
67 Li J, Han T, Wang X, Wang Y, Chen X, Chen W, Yang Q. Construction of a Novel Immune-Related mRNA Signature to Predict the Prognosis and Immune Characteristics of Human Colorectal Cancer. Front Genet 2022;13:851373. [DOI: 10.3389/fgene.2022.851373] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Liu J, Geng R, Ni S, Cai L, Yang S, Shao F, Bai J. Pyroptosis-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with UCEC. Mol Ther Nucleic Acids 2022;27:1036-55. [PMID: 35228898 DOI: 10.1016/j.omtn.2022.01.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
69 Ren X, Guo S, Guan X, Kang Y, Liu J, Yang X. Immunological Classification of Tumor Types and Advances in Precision Combination Immunotherapy. Front Immunol 2022;13:790113. [DOI: 10.3389/fimmu.2022.790113] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
70 Lu M, Li J, Fan X, Xie F, Fan J, Xiong Y. Novel Immune-Related Ferroptosis Signature in Esophageal Cancer: An Informatics Exploration of Biological Processes Related to the TMEM161B-AS1/hsa-miR-27a-3p/GCH1 Regulatory Network. Front Genet 2022;13:829384. [DOI: 10.3389/fgene.2022.829384] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
71 Liu R, Liang W, Hua Q, Wu L, Wang X, Li Q, Zhong F, Li B, Qiu Z. Fatty Acid Metabolic Signaling Pathway Alternation Predict Prognosis of Immune Checkpoint Inhibitors in Glioblastoma. Front Immunol 2022;13:819515. [DOI: 10.3389/fimmu.2022.819515] [Reference Citation Analysis]
72 Carlsen L, Huntington KE, El-deiry WS. Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers. Cancers 2022;14:1028. [DOI: 10.3390/cancers14041028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
73 Sorrentino C, D'Antonio L, Fieni C, Ciummo SL, Di Carlo E. Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival. Front Immunol 2021;12:778329. [PMID: 34975867 DOI: 10.3389/fimmu.2021.778329] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
74 Jia Z, Wan X. ISYNA1: An Immunomodulatory-Related Prognostic Biomarker in Colon Adenocarcinoma and Pan-Cancer. Front Cell Dev Biol 2022;10:792564. [DOI: 10.3389/fcell.2022.792564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Fleischmann M, Diefenhardt M, Fokas E, Rödel C, Rödel F. Molekulare Prädiktoren des Tumoransprechens auf neoadjuvante Radiochemotherapie des Rektumkarzinoms. Onkologe 2022;28:118-125. [DOI: 10.1007/s00761-021-01064-w] [Reference Citation Analysis]
76 Lin X, Deng J, Deng H, Yang Y, Sun N, Zhou M, Qin Y, Xie X, Li S, Zhong N, Song Y, Zhou C. Comprehensive Analysis of the Immune Microenvironment in Checkpoint Inhibitor Pneumonitis. Front Immunol 2021;12:818492. [PMID: 35095920 DOI: 10.3389/fimmu.2021.818492] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
77 Iseas S, Sendoya JM, Robbio J, Coraglio M, Kujaruk M, Mikolaitis V, Rizzolo M, Cabanne A, Ruiz G, Salanova R, Gualdrini U, Méndez G, Antelo M, Carballido M, Rotondaro C, Viglino J, Eleta M, Di Sibio A, Podhajcer OL, Roca E, Llera AS, Golubicki M, Abba MC. Prognostic Impact of An Integrative Landscape of Clinical, Immune, and Molecular Features in Non-Metastatic Rectal Cancer. Front Oncol 2021;11:801880. [PMID: 35071006 DOI: 10.3389/fonc.2021.801880] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
78 Chen Q, Xu L, Wu T, Li J, Hua L. Analysis of abnormal intestinal flora on risk of intestinal cancer and effect of heparin on formation of bacterial biofilm. Bioengineered 2022;13:894-904. [PMID: 34968154 DOI: 10.1080/21655979.2021.2014388] [Reference Citation Analysis]
79 He R, Lao Y, Yu W, Zhang X, Jiang M, Zhu C. Progress in the Application of Immune Checkpoint Inhibitor-Based Immunotherapy for Targeting Different Types of Colorectal Cancer. Front Oncol 2021;11:764618. [PMID: 34888243 DOI: 10.3389/fonc.2021.764618] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
80 Hu LF, Lan HR, Huang D, Li XM, Jin KT. Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand? Front Oncol 2021;11:769305. [PMID: 34888246 DOI: 10.3389/fonc.2021.769305] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
81 Dal Buono A, Gaiani F, Poliani L, Correale C, Laghi L. Defects in MMR Genes as a Seminal Example of Personalized Medicine: From Diagnosis to Therapy. J Pers Med 2021;11:1333. [PMID: 34945805 DOI: 10.3390/jpm11121333] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
82 Chen L, Zhou Q, Liu J, Zhang W. CTNNB1 Alternation Is a Potential Biomarker for Immunotherapy Prognosis in Patients With Hepatocellular Carcinoma. Front Immunol 2021;12:759565. [PMID: 34777372 DOI: 10.3389/fimmu.2021.759565] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
83 Lin A, Xu W, Luo P, Zhang J. Mutations Status of Chemokine Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colon Adenocarcinoma. Front Pharmacol 2021;12:721181. [PMID: 34721019 DOI: 10.3389/fphar.2021.721181] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
84 Li D, Lin X, Chen B, Ma Z, Zeng Y, Wang H. Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer. Front Genet 2021;12:723802. [PMID: 34659346 DOI: 10.3389/fgene.2021.723802] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
85 Prayugo FB, Kao TJ, Anuraga G, Ta HDK, Chuang JY, Lin LC, Wu YF, Wang CY, Lee KH. Expression Profiles and Prognostic Value of FABPs in Colorectal Adenocarcinomas. Biomedicines 2021;9:1460. [PMID: 34680577 DOI: 10.3390/biomedicines9101460] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
86 Peng L, Chang J, Liu X, Lu S, Ren H, Zhou X, Liu Z, Hu P. MC1R Is a Prognostic Marker and Its Expression Is Correlated with MSI in Colorectal Cancer. Curr Issues Mol Biol 2021;43:1529-47. [PMID: 34698109 DOI: 10.3390/cimb43030108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
87 Tan X, Li Q, Zhang Q, Fan G, Liu Z, Zhou K. Integrative Analysis Reveals Potentially Functional N6-Methylandenosine-Related Long Noncoding RNAs in Colon Adenocarcinoma. Front Genet 2021;12:739344. [PMID: 34603397 DOI: 10.3389/fgene.2021.739344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
88 Lin A, Zhang H, Meng H, Deng Z, Gu T, Luo P, Zhang J. TNF-Alpha Pathway Alternation Predicts Survival of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer. Front Immunol 2021;12:667875. [PMID: 34603277 DOI: 10.3389/fimmu.2021.667875] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
89 Zhang Y, Li X, Zhou R, Lin A, Cao M, Lyu Q, Luo P, Zhang J. Glycogen Metabolism Predicts the Efficacy of Immunotherapy for Urothelial Carcinoma. Front Pharmacol 2021;12:723066. [PMID: 34512351 DOI: 10.3389/fphar.2021.723066] [Reference Citation Analysis]
90 Gong S, Duan Y, Wu C, Osterhoff G, Schopow N, Kallendrusch S. A Human Pan-Cancer System Analysis of Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 3 (PLOD3). Int J Mol Sci 2021;22:9903. [PMID: 34576068 DOI: 10.3390/ijms22189903] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
91 Wang Z, Wang C, Lin S, Yu X. Effect of TTN Mutations on Immune Microenvironment and Efficacy of Immunotherapy in Lung Adenocarcinoma Patients. Front Oncol 2021;11:725292. [PMID: 34513703 DOI: 10.3389/fonc.2021.725292] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
92 Lin A, Wei T, Liang J, Qi C, Li M, Luo P, Zhang J. CAMOIP: A Web Server for Comprehensive Analysis on Multi-Omics of Immunotherapy in Pan-cancer.. [DOI: 10.1101/2021.09.10.459722] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
93 Lyu Q, Lin A, Cao M, Xu A, Luo P, Zhang J. Alterations in TP53 Are a Potential Biomarker of Bladder Cancer Patients Who Benefit From Immune Checkpoint Inhibition. Cancer Control 2020;27:1073274820976665. [PMID: 33356494 DOI: 10.1177/1073274820976665] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
94 Hu X, Zhu H, Zhang X, He X, Xu X. Comprehensive analysis of pan-cancer reveals potential of ASF1B as a prognostic and immunological biomarker. Cancer Med 2021;10:6897-916. [PMID: 34472711 DOI: 10.1002/cam4.4203] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
95 Xue W, Yang G, Karmakar B, Gao Y. Sustainable synthesis of Cu NPs decorated on pectin modified Fe3O4 nanocomposite: Catalytic synthesis of 1-substituted-1H-tetrazoles and in-vitro studies on its cytotoxicity and anti-colorectal adenocarcinoma effects on HT-29 cell lines. Arabian Journal of Chemistry 2021;14:103306. [DOI: 10.1016/j.arabjc.2021.103306] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
96 Ma SM, Dong J, Liang L, Liu XT, Meng XY, Zhang HS, Yang J. The prognostic and clinicopathological roles of microsatellite instability, PD-L1 expression and tumor-infiltrating leukocytes in familial adenomatous polyposis. Eur J Surg Oncol 2021:S0748-7983(21)00704-6. [PMID: 34483031 DOI: 10.1016/j.ejso.2021.08.032] [Reference Citation Analysis]
97 Palacín-Aliana I, García-Romero N, Asensi-Puig A, Carrión-Navarro J, González-Rumayor V, Ayuso-Sacido Á. Clinical Utility of Liquid Biopsy-Based Actionable Mutations Detected via ddPCR. Biomedicines 2021;9:906. [PMID: 34440110 DOI: 10.3390/biomedicines9080906] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
98 Zhou X, Liu Y, Xiang J, Wang Y, Wang Q, Xia J, Chen Y, Bai Y. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy. Front Immunol 2021;12:665002. [PMID: 34367132 DOI: 10.3389/fimmu.2021.665002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
99 Chen Y, Wang X, Deng X, Zhang Y, Liao R, Li Y, Yang H, Chen K. DNA Damage Repair Status Predicts Opposite Clinical Prognosis Immunotherapy and Non-Immunotherapy in Hepatocellular Carcinoma. Front Immunol 2021;12:676922. [PMID: 34335575 DOI: 10.3389/fimmu.2021.676922] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
100 Cheng T, Zhang J, Liu D, Lai G, Wen X. Prognosis of Non-small-cell Lung Cancer Patients With Lipid Metabolism Pathway Alternations to Immunotherapy. Front Genet 2021;12:646362. [PMID: 34335679 DOI: 10.3389/fgene.2021.646362] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
101 Li X, Wang Y, Li X, Feng G, Hu S, Bai Y. The Impact of NOTCH Pathway Alteration on Tumor Microenvironment and Clinical Survival of Immune Checkpoint Inhibitors in NSCLC. Front Immunol 2021;12:638763. [PMID: 34305884 DOI: 10.3389/fimmu.2021.638763] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
102 Amodio V, Mauri G, Reilly NM, Sartore-Bianchi A, Siena S, Bardelli A, Germano G. Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers. Cancers (Basel) 2021;13:2638. [PMID: 34072037 DOI: 10.3390/cancers13112638] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
103 Bai J, Chen H, Bai X. Relationship between microsatellite status and immune microenvironment of colorectal cancer and its application to diagnosis and treatment. J Clin Lab Anal 2021;35:e23810. [PMID: 33938589 DOI: 10.1002/jcla.23810] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
104 Blair TC, Alice AF, Zebertavage L, Crittenden MR, Gough MJ. The Dynamic Entropy of Tumor Immune Infiltrates: The Impact of Recirculation, Antigen-Specific Interactions, and Retention on T Cells in Tumors. Front Oncol 2021;11:653625. [PMID: 33968757 DOI: 10.3389/fonc.2021.653625] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
105 Corrò C, Dutoit V, Koessler T. Emerging Trends for Radio-Immunotherapy in Rectal Cancer. Cancers (Basel) 2021;13:1374. [PMID: 33803620 DOI: 10.3390/cancers13061374] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
106 Zhou Z, Xie X, Wang X, Zhang X, Li W, Sun T, Cai Y, Wu J, Dang C, Zhang H. Correlations Between Tumor Mutation Burden and Immunocyte Infiltration and Their Prognostic Value in Colon Cancer. Front Genet 2021;12:623424. [PMID: 33664769 DOI: 10.3389/fgene.2021.623424] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
107 Chen A, Zhang S, Xiong L, Xi S, Tao R, Chen C, Li J, Chen J, Li C. Investigation of an Alternative Marker for Hypermutability Evaluation in Different Tumors. Genes (Basel) 2021;12:197. [PMID: 33572856 DOI: 10.3390/genes12020197] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]